Printer Friendly

Cerebrospinal Fluid Management Device Pipeline Review 2015 Research Report Available at WiseGuyReports.com.

WiseGuyReports.com announces "Cerebrospinal Fluid Management - Pipeline Review, 2015" 65 Pages with tables and figures to its research store. The report provides an overview of Cerebrospinal Fluid Management products currently in pipeline stage.

NAGPUR, India, Sept. 24, 2015 /PRNewswire-iReach/ -- The Medical Devices sector report " Cerebrospinal Fluid Management - Pipeline Review, 2015" provides an overview of Cerebrospinal Fluid Management products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebrospinal Fluid Management pipeline products.

Photo - http://photos.prnewswire.com/prnh/20150924/270476

Major Companies mentioned in this report includes :

Aqueduct Neurosciences, Arkis BioSciences, Beckersmith Medical, Inc., Biosan Medical Ltd., Ceremed, Inc., CSF Therapeutics, Inc., Georgia Institute of Technology, H-Cubed Inc., Integra LifeSciences Holdings Corporation, InVivo Therapeutics Corporation, Kerecis ehf, Microbot Medical, Ltd., Nanonerve Inc., NexGen Medical Systems, Inc., Sree Chitra Tirunal Institute for Medical Sciences & Technology, System Science Inc., University Hospital Zurich, University of Colorado, University of Rochester, University of South Florida, University of Wisconsin Madison, Vivonics, Inc. and Wayne State University.

Make an Inquiry before purchasing this report @ https://www.wiseguyreports.com/enquiry/pharmasphere-emerging-biotechnologies-antisense-rnai-therapeutics-market-analysis.

Scope

- Extensive coverage of the Cerebrospinal Fluid Management products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Cerebrospinal Fluid Management products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Cerebrospinal Fluid Management products under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date

Check Discount on this report @ https://www.wiseguyreports.com/check_discount/cerebrospinal-fluid-management-pipeline-review-2015.

Major points in Table of Content

1.1 List of Tables Table 1: Alnylam Pharmaceuticals, Pipeline Programs, Phase I-III 41 Table 2: Alnylam Pharmaceuticals, Pipeline Programs, Preclinical 43 Table 3: Alnylam Pharmaceuticals, Pipeline Programs, Discovery 44 Table 4: Antisense Therapeutics 46 Table 5: Arrowhead Research Corporation 48 Table 6: AuraSense Therapeutics 50 Table 7: BioMarin Pharmaceuticals 52 Table 8: Dicerna Pharmaceuticals 54 Table 9: Gene Signal International SA 56 Table 10: Idera Pharmaceuticals 57 Table 11: InDex Pharmaceuticals AB 59 Table 12: Isarna Therapeutics GmbH 60 Table 13: Isis Pharmaceuticals, Pipeline Programs, Phase II-III 62 Table 14: Isis Pharmaceuticals, Pipeline Programs, Phase I 63 Table 15: Isis Pharmaceuticals, Pipeline Programs, Preclinical 64 Table 16: Miragen Therapeutics 66 Table 17: Mirna Therapeutics 67 Table 18: Moderna Therapeutics 68 Table 19: Mologen AG 70 Table 20: Oncogenex Pharmaceuticals 72 Table 21: Quark Pharmaceuticals 73 Table 22: Regulus Therapeutics 74 Table 23: RXi Pharmaceuticals 76 Table 24: Sarepta Therapeutics, Pipeline Programs, Preclinical-Phase III 78 Table 25: Sarepta Therapeutics, Pipeline Programs, Discovery 79 Table 26: Silence Therapeutics Plc 80 Table 27: Sirnaomics, Pipeline Programs, Preclinical 81 Table 28: Sterna Biologicals GmbH 82 Table 29: Sylentis SA 83 Table 30: Tekmira Pharmaceuticals, Pipeline Programs, Phase I-II 85 Table 31: Tekmira Pharmaceuticals, Pipeline Programs, Preclinical 87 Table 32: Antisense Therapy, M&A Deals Table Summary, 2010-2015 106 Table 33: Antisense Therapy, Licensing Deals Table Summary, 2010-2015 109 Table 34: Antisense Therapy, Licensing Deals Table Summary, Cont'd, 2010-2015 112 Table 35: Antisense Therapy, Capital Raisings Table Summary, 2012-2015 117

Get more details on Medical Devices industry @ https://www.wiseguyreports.com/categories/medical-devices.

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Media Contact: Norah Trent, WiseGuy Reports, +1 646 845 9349, sales@wiseguyreports.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE WiseGuy Reports
COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Cerebrospinal Fluid Management Device Pipeline Review 2015 Research Report Available at WiseGuyReports.com.
Publication:PR Newswire
Geographic Code:9INDI
Date:Sep 24, 2015
Words:952
Previous Article:Global Satellite M2M Connections and Services Market 2015-2019.
Next Article:Global Organic Food and Beverages Market 2015-2019.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters